Inevitable isolation and the change of stress markers in hemodialysis patients during the 2015 MERS-CoV outbreak in Korea

Scientific Reports

Volumn 9, Issue 1, 2019, Pages

  Kim, Yang Gyun ^a   Moon, Haena ^a   Kim, Se Yun ^a   Lee, Yu Ho ^a   Jeong, Da Wun ^a   Kim, Kipyo ^a   Moon, Ju Young ^a   Lee, Young Ki ^b   Cho, Ajin ^b   Lee, Hong Seock ^b   Park, Hayne Cho ^c   Lee, Sang Ho ^a  

^a Kyung Hee University Hospital   (South Korea)

^b Hallym University College of Medicine   (South Korea)

^c Armed Forces Capital Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CELL FREE NUCLEIC ACID; MITOCHONDRIAL DNA;

ADULT; BLOOD; CORONAVIRUS INFECTION; CROSS INFECTION; EPIDEMIC; FEMALE; HEMODIALYSIS; HUMAN; MALE; MIDDLE AGED; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; PATHOGENICITY; PROCEDURES; SOUTH KOREA; VIROLOGY;

ADULT; BIOMARKERS; CELL-FREE NUCLEIC ACIDS; CORONAVIRUS INFECTIONS; CROSS INFECTION; DISEASE OUTBREAKS; DNA, MITOCHONDRIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; RENAL DIALYSIS; REPUBLIC OF KOREA;

EID: 85064057123     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-019-41964-x     Document Type: Article

References (33)

1. Assiri, A. et al. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med 369, 407–416, 10.1056/NEJMoa1306742 (2013).
2. Moon, S. Y. et al. Middle East Respiratory Syndrome Coronavirus Transmission in Dialysis Unit and Infection Control Interventions in Korea. Infect Control Hosp Epidemiol 37, 1514–1516, 10.1017/ice.2016.201 (2016).
3. Butt, A. N. & Swaminathan, R. Overview of circulating nucleic acids in plasma/serum. Ann N Y Acad Sci 1137, 236–242, 10.1196/annals.1448.002 (2008).
4. Czamanski-Cohen, J. et al. Decrease in cell free DNA levels following participation in stress reduction techniques among women undergoing infertility treatment. Arch Womens Ment Health 17, 251–253, 10.1007/s00737-013-0407-2 (2014).
5. Lindqvist, D. et al. Circulating cell-free mitochondrial DNA, but not leukocyte mitochondrial DNA copy number, is elevated in major depressive disorder. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology 43, 1557–1564, 10.1038/s41386-017-0001-9 (2018).
6. Haller, N. et al. Circulating, cell-free DNA as a marker for exercise load in intermittent sports. PloS one 13, e0191915, 10.1371/journal.pone.0191915 (2018).
7. Cao, H. et al. Circulatory mitochondrial DNA is a pro-inflammatory agent in maintenance hemodialysis patients. PloS one 9, e113179, 10.1371/journal.pone.0113179 (2014).
8. Tovbin, D. et al. Circulating cell-free DNA in hemodialysis patients predicts mortality. Nephrol Dial Transplant 27, 3929–3935, 10.1093/ndt/gfs255 (2012).
9. Alles, V. V. et al. Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes. Blood 84, 3483–3493 (1994).
10. Meijers, B. K. et al. p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients. Clinical journal of the American Society of Nephrology: CJASN 4, 1932–1938, 10.2215/CJN.02940509 (2009).
11. Kandouz, S., Mohamed, A. S., Zheng, Y., Sandeman, S. & Davenport, A. Reduced protein bound uraemic toxins in vegetarian kidney failure patients treated by haemodiafiltration. Hemodialysis international. International Symposium on Home Hemodialysis 20, 610–617, 10.1111/hdi.12414 (2016).
12. Ro, J. S., Lee, J. S., Kang, S. C. & Jung, H. M. Worry experienced during the 2015 Middle East Respiratory Syndrome (MERS) pandemic in Korea. PloS one 12, e0173234, 10.1371/journal.pone.0173234 (2017).
13. Kim, J. S. & Choi, J. S. Factors Influencing Emergency Nurses’ Burnout During an Outbreak of Middle East Respiratory Syndrome Coronavirus in Korea. Asian Nurs Res (Korean Soc Nurs Sci) 10, 295–299, 10.1016/j.anr.2016.10.002 (2016).
14. Atamaniuk, J., Kopecky, C., Skoupy, S., Saemann, M. D. & Weichhart, T. Apoptotic cell-free DNA promotes inflammation in haemodialysis patients. Nephrol Dial Transplant 27, 902–905, 10.1093/ndt/gfr695 (2012).
15. Jeong, D. W. et al. Effect of blood pressure and glycemic control on the plasma cell-free DNA in hemodialysis patients. Kidney Res Clin Pract 34, 201–206, 10.1016/j.krcp.2015.09.002 (2015).
16. Nakahira, K. et al. Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validation. PLoS Med 10, e1001577; discussion e1001577, 10.1371/journal.pmed.1001577 (2013).
17. Zhang, Q. et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464, 104–107, 10.1038/nature08780 (2010).
18. Nagata, S., Nagase, H., Kawane, K., Mukae, N. & Fukuyama, H. Degradation of chromosomal DNA during apoptosis. Cell Death Differ 10, 108–116, 10.1038/sj.cdd.4401161 (2003).
19. Viorritto, I. C., Nikolov, N. P. & Siegel, R. M. Autoimmunity versus tolerance: can dying cells tip the balance? Clin Immunol 122, 125–134, 10.1016/j.clim.2006.07.012 (2007).
20. Carracedo, J. et al. Cell apoptosis and hemodialysis-induced inflammation. Kidney Int Suppl, 89–93, 10.1046/j.1523-1755.61.s80.17.x (2002).
21. Kato, S. et al. Aspects of immune dysfunction in end-stage renal disease. Clinical journal of the American Society of Nephrology: CJASN 3, 1526–1533, 10.2215/CJN.00950208 (2008).
22. Picard, M., Juster, R. P. & McEwen, B. S. Mitochondrial allostatic load puts the ‘gluc’ back in glucocorticoids. Nature reviews. Endocrinology 10, 303–310, 10.1038/nrendo.2014.22 (2014).
23. Cai, N. et al. Molecular signatures of major depression. Current biology: CB 25, 1146–1156, 10.1016/j.cub.2015.03.008 (2015).
24. Burbeck, R., Coomber, S., Robinson, S. M. & Todd, C. Occupational stress in consultants in accident and emergency medicine: a national survey of levels of stress at work. Emerg Med J 19, 234–238 (2002).
25. Horowitz, M., Wilner, N. & Alvarez, W. Impact of Event Scale: a measure of subjective stress. Psychosom Med 41, 209–218 (1979).
26. Reynolds, D. L. et al. Understanding, compliance and psychological impact of the SARS quarantine experience. Epidemiol Infect 136, 997–1007, 10.1017/S0950268807009156 (2008).
27. Klouche, M. et al. Modified atherogenic lipoproteins induce expression of pentraxin-3 by human vascular smooth muscle cells. Atherosclerosis 175, 221–228, 10.1016/j.atherosclerosis.2004.03.020 (2004).
28. Tong, M. et al. Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality. Clinical journal of the American Society of Nephrology: CJASN 2, 889–897, 10.2215/CJN.00870207 (2007).
29. Boehme, M. et al. Pentraxin 3 is elevated in haemodialysis patients and is associated with cardiovascular disease. Nephrol Dial Transplant 22, 2224–2229, 10.1093/ndt/gfl747 (2007).
30. Quan, H. et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. American journal of epidemiology 173, 676–682, 10.1093/aje/kwq433 (2011).
31. Clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis 48 Suppl 1, S2–90, 10.1053/j.ajkd.2006.03.051 (2006).
32. Al, Z. ’abi,M., Ali, B. & Al Toubi, M. HPLC-fluorescence method for measurement of the uremic toxin indoxyl sulfate in plasma. Journal of chromatographic science 51, 40–43, 10.1093/chromsci/bms103 (2013).
33. Nga, T. V. et al. The sensitivity of real-time PCR amplification targeting invasive Salmonella serovars in biological specimens. BMC Infect Dis 10, 125, 10.1186/1471-2334-10-125 (2010).